A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/569 (2006.01) A61K 9/16 (2006.01) A61K 9/20 (2006.01) A61P 9/00 (2006.01) A61P 9/12 (2006.01)
Patent
CA 2681021
The invention relates to single-phase oral contraceptives comprising a combination of 2.0 mg dienogest of the non-aldosterone antagonist type and 0.030 mg ethinyl estradiol or 2.0 mg dienogest and 0.020 mg ethinyl estradiol or 2.0 mg dienogest and 0.015 mg ethinyl estradiol or 1.5 mg dienogest and 0.015 mg ethinyl estradiol in at least (21) daily dosage units. Said oral contraceptives achieve a regulation of blood pressure - reducing elevated blood pressure and increasing depressed blood pressure - during contraception. Said oral contraceptives are particularly suitable for long-term contraceptive use without the risk of negative influence on blood pressure.
L'invention concerne des contraceptifs oraux monophasiques qui contiennent une combinaison de 2.0 mg de diénogest du type non-antagoniste de l'aldostérone et de 0.030 mg d'éthinylestradiol, de 2.0 mg de diénogest et de 0.020 mg d'éthinylestradiol, de 2.0 mg de diénogest et de 0.015 mg d'éthinylestradiol ou de 1.5 mg de diénogest et de 0.015 mg d'éthinylestradiol en au moins 21 unités correspondant à la dose quotidienne. Ces contraceptifs permettent une régulation de la pression artérielle - abaissement d'une hypertension, augmentation d'une hypotension - pendant la contraception. Ils conviennent en particulier à une utilisation contraceptive de longue durée sans risque d'influence négative sur la pression artérielle.
Mittmann Katrin
Zimmermann Thomas
Bayer Schering Pharma Aktiengesellschaft
Marks & Clerk
LandOfFree
Single-phase pharmaceutical composite preparation (dienogest... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Single-phase pharmaceutical composite preparation (dienogest..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Single-phase pharmaceutical composite preparation (dienogest... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1565615